About Us |
PMID | 27517483 |
Gene Name | CRISP2 |
Condition | Asthenoteratozoospermia, Male infertility |
Association |
Associated |
Sex | Male |
Infertility type | Male infertility |
Other associated phenotypes |
Asthenoteratozoospermia, Male infertility |
MicroRNA-27a-mediated repression of cysteine-rich secretory protein 2 translation in asthenoteratozoospermic patients Zhou JH, Zhou QZ, Yang JK, Lyu XM, Bian J, Guo WB, Chen ZJ, Xia M, Xia H, Qi T, Li X, Liu CD. Cysteine-rich secretory protein 2 (CRISP2) is an important protein in spermatozoa that plays roles in modulating sperm flagellar motility, the acrosome reaction, and gamete fusion. Spermatozoa lacking CRISP2 exhibit low sperm motility and abnormal morphology. However, the molecular mechanisms underlying the reduction of CRISP2 in asthenoteratozoospermia (ATZ) remain unknown. In this study, low expression of CRISP2 protein rather than its mRNA was observed in the ejaculated spermatozoa from ATZ patients as compared with normozoospermic males. Subsequently, bioinformatic prediction, luciferase reporter assays, and microRNA-27a (miR-27a) transfection experiments revealed that miR-27a specifically targets CRISP2 by binding to its 3' untranslated region (3'-UTR), suppressing CRISP2 expression posttranscriptionally. Further evidence was provided by the clinical observation of high miR-27a expression in ejaculated spermatozoa from ATZ patients and a negative correlation between miR-27a expression and CRISP2 protein expression. Finally, a retrospective follow-up study supported that both high miR-27a expression and low CRISP2 protein expression were associated with low progressive sperm motility, abnormal morphology, and infertility. This study demonstrates a novel mechanism responsible for reduced CRISP2 expression in ATZ, which may offer a potential therapeutic target for treating male infertility, or for male contraception. FAU - Zhou, Jun-Hao AU - Zhou JH AD - Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China. FAU - Zhou, Qi-Zhao AU - Zhou QZ AD - Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China. FAU - Yang, Jian-Kun AU - Yang JK AD - Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China. FAU - Lyu, Xiao-Ming AU - Lyu XM AD - Laboratory Medical Center, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China. FAU - Bian, Jun AU - Bian J AD - Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China. FAU - Guo, Wen-Bin AU - Guo WB AD - Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China. FAU - Chen, Zi-Jian AU - Chen ZJ AD - Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China. FAU - Xia, Ming AU - Xia M AD - Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China. FAU - Xia, Hui AU - Xia H AD - Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China. FAU - Qi, Tao AU - Qi T AD - Laboratory Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, China. FAU - Li, Xin AU - Li X AD - Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China. AD - Cancer Research Institute, Southern Medical University, Guangzhou, China. |